Caregivers of children with Dravet syndrome in Sweden reported a number of factors, including fever, infections, physical activity,…
Articles by Lindsey Shapiro, PhD
Six months of treatment with the oral cannabidiol (CBD) solution Epidiolex among children and adolescents with Dravet syndrome…
The first healthy volunteer has been dosed in a Phase 1 trial of BMB-101, Bright Minds Biosciences‘ investigational treatment…
Although the use of cannabidiol (CBD) is associated with reduced seizure frequency in children with Dravet syndrome, various cannabinoid-based…
Up to three years of treatment with the anti-seizure medication Fintepla (fenfluramine) did not result in any signs of valvular…
The prevalence of Dravet syndrome in Sweden was one in 45,000 at the end of 2018, with most identified…
Anticonvulsant therapies in the benzodiazepine class successfully suppressed nearly 62% of all episodes of status epilepticus in children with Dravet…
A type of brain nerve cells, called parvalbumin-expressing (PV) interneurons, was able to generate electrical signals in a mouse model…